A new testing kit has been launched in the UAE for detecting COVID-19 antibodies in people.
It will support the efforts of frontline workers and will also help organisations with the return of their employees to the workplace.
The serology test kits can determine whether individuals have been exposed to the virus and have developed antibodies.
However, they are not meant to replace the traditional RT- PCR testing, and will instead complement its efforts.
The Abu Dhabi-based National Reference Laboratory (NRL), part of Mubadala Healthcare’s network, has announced plans to release the kits to the local market.
While acknowledging that Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) testing remains the gold standard for diagnosing COVID-19, NRL experts are highlighting the benefits of their new serology test kits, stating these complementary antibody tests provide useful information for treating the disease and analyzing its spread, as well as having potential implications for human resource planning.
"While anyone can take these tests to determine whether they have been exposed to the virus and have developed antibodies, it does not mean they can ignore precautions, more studies are needed on the protective nature of the antibodies," said Dr. Laila Abdel Wareth, NRL’s Deputy CEO and Chief Scientific Officer.


UAE fines 42 domestic worker recruitment firms for violating rules
Dubai's RTA expands e-bike delivery service to seven new areas
Sharjah Charity sends food aid to Bangladesh flood victims
UAE condemns Israeli settler attacks in occupied West Bank
President commends global humanitarian efforts of UAE Search and Rescue Team
UAE discusses regional developments with Qatar, Oman
Dubai Police launch doorstep service for lost-and-found items
UAE expresses solidarity with France over wildfires
